High-flow nasal oxygen in patients with COVID-19-associated acute respiratory failure
ccforum.biomedcentral.comThe use of high-flow nasal oxygen upon ICU admission in adult patients with COVID-19 related acute hypoxemic respiratory failure may lead to an increase in ventilator-free days and a reduction in ICU length of stay, when compared to early initiation of invasive mechanical ventilation. Future studies should confirm our findings.
This was a multicentre cohort study using a prospectively collected database of patients with COVID-19 associated acute respiratory failure admitted to 36 Spanish and Andorran intensive care units (ICUs).
Out of 468 eligible patients, a total of 122 matched patients were included in the present analysis (61 for each group).
When compared to early intubation, the use of high-flow nasal oxygen was associated with an increase in ventilator-free days and a reduction in ICU length of stay.